Rauf R, Soomro MI, Khan MN, Kumar M, Soomro NA, Kazmi KA. Assessment of post-myocardial infarction lipid levels and management: Results from a tertiary care hospital of Pakistan. World J Cardiol 2024; 16(5): 282-292 [PMID: 38817645 DOI: 10.4330/wjc.v16.i5.282]
Corresponding Author of This Article
Rubina Rauf, FCPS, Assistant Professor, Department of Preventive Cardiology, National Institute of Cardiovascular Diseases, Rafiqui (H.J.) Shaheed Road, Karachi 75510, Pakistan. drrubinarauf@gmail.com
Research Domain of This Article
Cardiac & Cardiovascular Systems
Article-Type of This Article
Observational Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Cardiol. May 26, 2024; 16(5): 282-292 Published online May 26, 2024. doi: 10.4330/wjc.v16.i5.282
Table 1 Distribution of demographic and clinical characteristics of post-acute myocardial infarction patients, n (%)
Total
Statin therapy
P value
Not on recommended dose
On recommended dose
Total
195
22 (11.3)
173 (88.7)
-
Gender
Male
139 (71.3)
15 (68.2)
124 (71.7)
0.733
Female
56 (28.7)
7 (31.8)
49 (28.3)
Age (mean ± SD, yr)
57.1 ± 10.2
57.8 ± 11.6
57 ± 10
0.728
≤ 40
11 (5.6)
2 (9.1)
9 (5.2)
0.558
41-65
150 (76.9)
15 (68.2)
135 (78)
> 65
34 (17.4)
5 (22.7)
29 (16.8)
Weight (mean ± SD, kg)
73.4 ± 14.7
76.6 ± 15.2
72.9 ± 14.6
0.268
Height (mean ± SD, cm)
155.5 ± 7.7
159.9 ± 7.5
154.9 ± 7.5
0.004
Body mass index (mean ± SD, kg/m2)
30.4 ± 5.8
30.2 ± 6.6
30.4 ± 5.8
0.857
Underweight (< 18.5)
1 (0.5)
0 (0)
1 (0.6)
0.185
Healthy weight (18.5-22.9)
16 (8.2)
4 (18.2)
12 (6.9)
Above ideal range (≥ 23)
178 (91.3)
18 (81.8)
160 (92.5)
Waist circumference (mean ± SD, cm)
97.2 ± 8.8
101.5 ± 11.7
96.7 ± 8.2
0.016
DM
82 (42.1)
11 (50)
71 (41)
0.423
Duration of DM (mean ± SD)
9.1 ± 5.3
9.5 ± 6.2
9.1 ± 5.2
0.832
Well controlled
13 (15.9)
3 (27.3)
10 (14.1)
0.265
HTN
100 (51.3)
12 (54.5)
88 (50.9)
0.745
Duration of HTN (mean ± SD)
8.1 ± 4.4
6.9 ± 3.4
8.2 ± 4.5
0.342
Well controlled
54 (54)
11 (91.7)
43 (48.9)
0.005
Tobacco
83 (42.6)
6 (27.3)
77 (44.5)
0.124
Duration of tobacco use (mean ± SD)
19.1 ± 9.1
15.4 ± 8.2
19.4 ± 9.2
0.296
Chewing
6 (7.2)
2 (33.3)
4 (5.2)
0.073
Chewing, smoking
6 (7.2)
0 (0)
6 (7.8)
Smoking
71 (85.5)
4 (66.7)
67 (87)
Family history of coronary artery diseases
101 (51.8)
17 (77.3)
84 (48.6)
0.011
AMI
STEMI
117 (60)
15 (68.2)
102 (59)
0.406
NSTEMI
78 (40)
7 (31.8)
71 (41)
Duration science first event of AMI (month)
36 (10-48)
36 (10-72)
30 (10-48)
0.299
Number of hospital admissions (in last 12 months)
0
167 (85.6)
15 (68.2)
152 (87.9)
0.001
1
23 (11.8)
4 (18.2)
19 (11)
2
5 (2.6)
3 (13.6)
2 (1.2)
Lipid profile advised after AMI
27 (13.8)
6 (27.3)
21 (12.1)
0.053
Are you taken statins after 1st event of AMI?
185 (94.9)
12 (54.5)
173 (100)
< 0.001
Duration [median (IQR), month]
24 (9-48)
26 (6.5-66)
24 (10-48)
0.818
What is the dose of statin you are taking?
Rosuvastatin
179 (91.8)
7 (31.8)
172 (99.4)
-
Not taking
16 (8.2)
15 (68.2)
1 (0.6)
< 0.001
10 mg
7 (3.6)
7 (31.8)
0 (0)
20 mg
172 (88.2)
0 (0)
172 (99.4)
Atervastatin
5 (2.6)
4 (18.2)
1 (0.6)
-
Not taking
190 (97.4)
18 (81.8)
172 (99.4)
< 0.001
20 mg
4 (2.1)
4 (18.2)
0 (0)
40 mg
1 (0.5)
0 (0)
1 (0.6)
Simvastatin
1 (0.5)
1 (4.5)
0 (0)
-
Not taking
194 (99.5)
21 (95.5)
173 (100)
0.005
10 mg
1 (0.5)
1 (4.5)
0 (0)
Did you ever lipid profile get done before AMI event?
4 (2.1)
1 (4.5)
3 (1.7)
0.381
Total cholesterol (last lipid profile)
Available
191 (97.9)
22 (100)
169 (97.7)
-
Level (mean ± SD)
143.1 ± 38.7
143 ± 35.6
143.1 ± 39.2
0.986
Level [median (IQR)]
140 (115-165)
136 (115-165)
144 (115-163)
0.818
Target total cholesterol (< 160)
137 (71.7)
16 (72.7)
121 (71.6)
0.912
LDL-cholesterol (last lipid profile)
Available
191 (97.9)
21 (95.5)
170 (98.3)
-
Level (mean ± SD)
91.7 ± 34.8
94.7 ± 42.5
91.3 ± 33.8
0.676
Level [median (IQR)]
88 (66-110)
83 (65-94)
88.5 (67-110)
0.989
Target LDL cholesterol (< 55)
22 (11.5)
2 (9.5)
20 (11.8)
0.762
HDL-cholesterol (last lipid profile)
Available
192 (98.5)
22 (100)
170 (98.3)
-
Level (mean ± SD)
40.9 ± 8.7
41.2 ± 10
40.8 ± 8.6
0.846
Level [median (IQR)]
42 (36-45)
42.5 (37-49)
41.5 (36-45)
0.466
Triglycerides (last lipid profile)
Available
165 (84.6)
17 (77.3)
148 (85.5)
-
Level (mean ± SD)
167.6 ± 76.4
185.4 ± 125
165.5 ± 69.1
0.311
Level [median (IQR)]
150 (123-190)
152 (125-167)]
150 (123-190)
0.782
Were you taken statins before 1st event of AMI?
3 (1.5)
0 (0)
3 (1.7)
0.534
Duration [median (IQR), month]
36 (12-48)
-
36 (12-48)
-
History of subsequent ACS event
16 (8.2)
3 (13.6)
13 (7.5)
0.324
Compliant to the statin therapy
179 (91.8)
12 (54.5)
167 (96.5)
< 0.001
If no what are the reasons?
Affordability
15 (7.7)
9 (40.9)
6 (3.5)
< 0.001
Dizziness
1 (0.5)
1 (4.5)
0 (0)
Table 2 Univariate and multivariable binary logistic regression analysis for the clinical associates of the target total cholesterol
Target total cholesterol (< 160)
Univariate
Multivariable
OR (95%CI)
P value
OR (95%CI)
P value
Gender
Male
1
-
1
-
Female
1.07 (0.53-2.16)
0.845
1.43 (0.61-3.38)
0.411
Age (yr)
≤ 40
1
-
1
-
41-65
0.23 (0.03-1.88)
0.172
0.18 (0.02-1.53)
0.116
> 65
0.27 (0.03-2.39)
0.238
0.18 (0.02-1.74)
0.137
Body mass index (kg/m2)
< 23
1
-
1
-
≥ 23
0.76 (0.24-2.45)
0.650
0.75 (0.2-2.73)
0.657
Waist circumference (cm)
0.99 (0.96-1.03)
0.743
1 (0.95-1.04)
0.859
DM
Non-DM
1
-
1
-
DM
0.96 (0.51-1.82)
0.901
0.94 (0.47-1.87)
0.864
HTN
Non-HTN
1
-
1
-
HTN
0.97 (0.52-1.82)
0.925
1.06 (0.55-2.06)
0.854
Tobacco user
No
1
-
1
-
Yes
1.22 (0.64-2.33)
0.537
1.43 (0.66-3.14)
0.366
Family history of coronary artery diseases
No
1
-
1
-
Yes
1.03 (0.55-1.93)
0.930
0.94 (0.48-1.81)
0.843
Acute myocardial infarction
STEMI
1
-
1
-
NSTEMI
0.98 (0.51-1.85)
0.940
1.05 (0.54-2.04)
0.893
Lipid profile advised after acute myocardial infarction
No
1
-
1
-
Yes
0.71 (0.29-1.7)
0.441
0.58 (0.23-1.47)
0.247
Statin therapy after acute myocardial infarction
No
1
-
1
-
Yes
0.62 (0.13-3.02)
0.554
0.52 (0.1-2.78)
0.446
Table 3 Univariate and multivariable binary logistic regression analysis for the clinical associates of the target low-density lipoprotein cholesterol
Target LDL cholesterol (< 55)
Univariate
Multivariable
OR (95%CI)
P value
OR (95%CI)
P value
Gender
Male
1
-
1
-
Female
1.18 (0.45-3.06)
0.739
1.09 (0.32-3.72)
0.884
Age (yr)
≤ 40
1
-
1
-
41-65
0.2 (0.05-0.76)
0.018
0.17 (0.03-0.85)
0.031
> 65
0.18 (0.03-0.97)
0.046
0.14 (0.02-1.07)
0.058
Body mass index (kg/m2)
< 23
1
-
1
-
≥ 23
0.57 (0.15-2.17)
0.412
0.34 (0.06-1.84)
0.211
Waist circumference (cm)
1.02 (0.97-1.08)
0.354
1.04 (0.98-1.11)
0.210
DM
Non-DM
1
-
1
-
DM
0.61 (0.24-1.58)
0.312
0.4 (0.14-1.17)
0.094
HTN
Non-HTN
1
-
1
-
HTN
0.92 (0.38-2.24)
0.855
0.96 (0.35-2.68)
0.942
Tobacco user
No
1
-
1
-
Yes
0.6 (0.23-1.54)
0.289
0.59 (0.18-1.93)
0.386
Family history of coronary artery diseases
No
1
-
1
-
Yes
1.39 (0.57-3.44)
0.470
1.42 (0.53-3.84)
0.485
Acute myocardial infarction
STEMI
1
-
1
-
NSTEMI
0.4 (0.14-1.12)
0.082
0.41 (0.13-1.31)
0.133
Lipid profile advised after acute myocardial infarction
No
1
-
1
-
Yes
0.27 (0.04-2.13)
0.216
0.15 (0.02-1.39)
0.095
Statin therapy after acute myocardial infarction
No
1
-
1
-
Yes
1.04 (0.12-8.76)
0.969
1.45 (0.11-18.39)
0.775
Table 4 Univariate and multivariable binary logistic regression analysis for the clinical associates of the recommended dose of statin
Recommended dose of statin
Univariate
Multivariable
OR (95%CI)
P value
OR (95%CI)
P value
Gender
Male
1
-
1
-
Female
0.85 (0.33-2.2)
0.733
1.91 (0.55-6.67)
0.325
Age (yr)
≤ 40
1
-
1
-
41-65
2 (0.39-10.13)
0.402
1.58 (0.25-9.99)
0.395
> 65
1.29 (0.21-7.82)
0.783
0.48 (0.06-4.09)
0.213
Body mass index (kg/m2)
< 23
1
-
1
-
≥ 23
2.74 (0.81-9.28)
0.107
14 (2.42-80.95)
0.806
Waist circumference (cm)
0.94 (0.89-0.99)
0.018
0.89 (0.83-0.95)
0.890
DM
Non-DM
1
-
1
-
DM
0.7 (0.29-1.69)
0.424
0.64 (0.23-1.79)
0.286
HTN
Non-HTN
1
-
1
-
HTN
0.86 (0.35-2.1)
0.745
1.38 (0.47-4.03)
0.354
Tobacco user
No
1
-
1
-
Yes
2.14 (0.8-5.73)
0.130
2.08 (0.58-7.51)
0.799
Family history of coronary artery diseases
No
1
-
1
-
Yes
0.28 (0.1-0.79)
0.016
0.2 (0.06-0.64)
0.098
Acute myocardial infarction
STEMI
1
-
1
-
NSTEMI
1.49 (0.58-3.84)
0.408
1.6 (0.51-5.06)
0.579
Lipid profile advised after acute myocardial infarction
No
1
-
1
-
Yes
0.37 (0.13-1.05)
0.061
0.21 (0.06-0.74)
0.130
Citation: Rauf R, Soomro MI, Khan MN, Kumar M, Soomro NA, Kazmi KA. Assessment of post-myocardial infarction lipid levels and management: Results from a tertiary care hospital of Pakistan. World J Cardiol 2024; 16(5): 282-292